摘要
【摘 要】目的：评价硝普钠联合多巴胺治疗顽固性心衰的临床疗效。方法：以我院 2018 年 1 月 -2019 年 6 月收治的 82 例顽固性心衰患者作为实验对象，根据临床用药方式分作 2 组，参照组 41 例患者采用常规治疗方式，研讨组 41 例患者在此基础上采用硝普钠联合多巴胺进行治疗，评价其临床疗效。结果：治疗后两组患者的指标均有所下降，而研讨组指标均较参照组下降程度更甚，研讨组治疗效率为 90.24% 相比参照组 56.10% 有明显提升，组间对比差异显著，研究结果存在统计学意义（ P<0.05 ）。结论：硝普钠联合多巴胺治疗顽固性心衰的临床疗效显著，不但能够缓解患者的临床症状，同时改善患者的心功能水平。
【关键词】硝普钠 ; 多巴胺 ; 顽固性心衰 ; 临床疗效 ; 评价
[Abstract] Objective: To evaluate the clinical efficacy of sodium nitroprusside combined with dopamine in the treatment of refractory heart failure. Methods: 82 patients with refractory heart failure admitted to our hospital from January 2018 to June 2019 were divided into two groups according to clinical medication. 41 patients in the reference group were treated with conventional therapy, 41 patients in the study group were treated with sodium nitroprusside combined with dopamine on this basis, and their clinical efficacy was evaluated. Results: the indexes of the two groups of patients decreased after treatment, and the indexes of the study group decreased even more than those of the reference group. the treatment efficiency of the study group was 90.24%, which was significantly improved compared with 56.10% of the reference group. the differences between the two groups were significant, and the research results were statistically significant (P<0.05). Conclusion: Sodium nitroprusside combined with dopamine has a significant clinical effect in the treatment of refractory heart failure, which can not only relieve the clinical symptoms of patients, but also improve the cardiac function level of patients.
出版日期
2020年04月20日（中国期刊网平台首次上网日期，不代表论文的发表时间）
